Impact of Biologic Therapy on Key Cardiovascular Risk Parameters in a Psoriatic Cohort-a Retrospective Review.

Joseph JosephKelvin TruongSerigne N LoFiona FooSarah ZamanClara K ChowAnnika Smith

Published in: Dermatology and therapy (2024)

In patients with psoriasis, markers of cardiovascular disease risk did not improve after 1 year of biologic therapy despite significant improvements in psoriasis skin severity.

Keyphrases

rheumatoid arthritis
cardiovascular disease
metabolic syndrome
mesenchymal stem cells
systemic lupus erythematosus
soft tissue
wound healing
cardiovascular risk factors